Lipid-Lowering Therapy in Patients with Average Cholesterol and High Cardiovascular Risk, Insights from the Heart Protection Study

Author： Salam Amar

Publisher： Springer Publishing Company

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.18, Iss.5, 2004-09, pp. : 387-389

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preventing Cardiovascular Outcome in Patients with Renal Impairment: Is There a Role for Lipid-Lowering Therapy?

By Holdaas Hallvard

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 4, 2005-01 ,pp. : 255-269

Adis International

Access to resources Recommend Favorite

Consider lipid-lowering therapy for patients with diabetes and hyperlipidaemia

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 283, 2000-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Lipid-lowering Drug Therapy in Elderly Patients

Current Pharmaceutical Design, Vol. 17, Iss. 9, 2011-03 ,pp. : 877-893

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of Lipid-Lowering Therapy and Cholesterol Goal Attainment in Finland: The National FINRISK Study

By Alemao Evo

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 5, 2006-01 ,pp. : 349-355

Adis International

Access to resources Recommend Favorite

Lipid-lowering therapy in diabetes

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 342, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite